Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases

NCT02065466 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of accrual

Conditions

Metastatic Melanoma
Brain Metastases

Interventions

DRUG: nab-paclitaxel
DRUG: Temozolomide
DRUG: Bevacizumab

Sponsor

University of Arizona